![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Shengtai Pharmaceutical Inc (GM) | USOTC:SGTI | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.000001 | 0.000001 | 0.000001 | 0.00 | 01:00:00 |
Delaware
|
000-51312
|
54-2155579
|
||
(State
or other jurisdiction of incorporation or organization)
|
(Commission
File Number)
|
(I.R.S.
Employer Identification No.)
|
o |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
o |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
o |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item
5.07.
|
Submission
of Matters to a Vote of Security
Holders.
|
|
1.
|
The
election of five directors to serve a one-year term expiring at the 2011
annual general meeting of stockholders and until their successors have
been elected and qualified.
|
Nominee
|
For
|
Against
|
Abstentions
|
|||
Qingtai
LIU
|
11,770,733
|
3,250
|
90,731
|
|||
Yongqiang
WANG
|
11,487,313
|
348,901
|
28,500
|
|||
Winfred
LEE
|
11,487,313
|
348,901
|
28,500
|
|||
Yaojun
LIU
|
11,770,733
|
3,250
|
90,731
|
|||
Fei
HE
|
11,832,964
|
3.250
|
28,500
|
|
2.
|
The
authorization to the Company’s Board of Directors to effect a reverse
stock split of issued and outstanding shares of the Company’s Common Stock
at a 1 for 2 ratio and, if and when the reverse stock split is effected,
to reduce the number of the Company’s authorized shares of Common Stock
and Preferred Stock by the same reverse stock split ratio and file any
required amendment to the Company’s Amended and Restated Certificate of
Incorporation to effect the same.
|
Matter
|
For
|
Against
|
|||
Approval
of the reverse stock split and the reduction of the Company’s authorized
shares of Common Stock and Preferred Stock by the same reverse stock split
ratio and the filing of an amendment to the Company’s Amended and Restated
Certificate of Incorporation to effect the same
|
11,829,263
|
34,451
|
|
3.
|
The
approval of the appointment of Kabani & Company, Inc. to serve as the
Company’s independent registered public accounting firm for the fiscal
year ending June 30, 2011.
|
Matter
|
For
|
Against
|
|||
Approval
of the appointment of Kabani & Company, Inc.
|
11,808,208
|
3,182,042
|
SHENGTAI
PHARMACEUTICAL, INC.
|
|||
Dated:
October 28, 2010
|
By:
|
/s/ Qingtai Liu | |
Name: Qingtai Liu | |||
Title: Chief Executive Officer | |||
1 Year Shengtai Pharmaceutical (GM) Chart |
1 Month Shengtai Pharmaceutical (GM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions